NO20045504L - Substituted thiophenes, methods of preparation, their use as a drug or diagnostic agent, and a drug containing these - Google Patents

Substituted thiophenes, methods of preparation, their use as a drug or diagnostic agent, and a drug containing these

Info

Publication number
NO20045504L
NO20045504L NO20045504A NO20045504A NO20045504L NO 20045504 L NO20045504 L NO 20045504L NO 20045504 A NO20045504 A NO 20045504A NO 20045504 A NO20045504 A NO 20045504A NO 20045504 L NO20045504 L NO 20045504L
Authority
NO
Norway
Prior art keywords
drug
preparation
methods
diagnostic agent
substituted thiophenes
Prior art date
Application number
NO20045504A
Other languages
Norwegian (no)
Other versions
NO329351B1 (en
Inventor
Klaus Wirth
Hans-Jochen Lang
Armin Hofmeister
Markus Bleich
Michael Gekle
Uwe Heinelt
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20045504L publication Critical patent/NO20045504L/en
Publication of NO329351B1 publication Critical patent/NO329351B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
NO20045504A 2002-06-04 2004-12-16 Substituted thiophene, its use and drug for human or veterinary use NO329351B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10224892A DE10224892A1 (en) 2002-06-04 2002-06-04 Substituted thiophenes, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them
PCT/EP2003/005465 WO2003101984A1 (en) 2002-06-04 2003-05-26 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same

Publications (2)

Publication Number Publication Date
NO20045504L true NO20045504L (en) 2005-01-25
NO329351B1 NO329351B1 (en) 2010-10-04

Family

ID=29557542

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20045504A NO329351B1 (en) 2002-06-04 2004-12-16 Substituted thiophene, its use and drug for human or veterinary use

Country Status (33)

Country Link
EP (1) EP1513834B1 (en)
JP (1) JP4511924B2 (en)
KR (1) KR101087966B1 (en)
CN (1) CN1324024C (en)
AR (1) AR040239A1 (en)
AT (1) ATE320425T1 (en)
AU (1) AU2003273553B2 (en)
BR (1) BR0311548A (en)
CA (1) CA2488242C (en)
CR (1) CR7577A (en)
DE (2) DE10224892A1 (en)
DK (1) DK1513834T3 (en)
EC (1) ECSP045471A (en)
ES (1) ES2258722T3 (en)
HK (1) HK1076460A1 (en)
HR (1) HRP20041153A2 (en)
IL (1) IL165519A (en)
MA (1) MA27204A1 (en)
ME (1) MEP27608A (en)
MX (1) MXPA04011986A (en)
MY (1) MY129832A (en)
NO (1) NO329351B1 (en)
OA (1) OA12827A (en)
PE (1) PE20040534A1 (en)
PL (1) PL372589A1 (en)
PT (1) PT1513834E (en)
RS (1) RS51141B (en)
RU (1) RU2315766C2 (en)
TN (1) TNSN04240A1 (en)
TW (1) TWI283675B (en)
UA (1) UA77551C2 (en)
WO (1) WO2003101984A1 (en)
ZA (1) ZA200409095B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040242560A1 (en) 2003-05-22 2004-12-02 Aventis Pharma Deutschland Gmbh Process for synthesizing heterocyclic compounds
DE10323701A1 (en) 2003-05-22 2004-12-23 Aventis Pharma Deutschland Gmbh Process for the synthesis of heterocyclic compounds
ES2545903T3 (en) 2003-06-30 2015-09-16 Sumitomo Chemical Company, Limited Asymmetric urea compounds and process for producing asymmetric compounds by reaction of asymmetric addition of conjugate using said compounds as catalyst
US20100056515A1 (en) * 2006-10-25 2010-03-04 Kazuyoshi Aso Benzimidazole compounds
US8822449B2 (en) 2008-09-02 2014-09-02 Sanofi Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
WO2011058139A1 (en) * 2009-11-12 2011-05-19 Selvita Sp. Z O. O. A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent
RU2518740C1 (en) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" METHOD, INHIBITING Na+/H+-EXCHANGE, AND DIHYDROCHLORIDE OF 2-(3,4-METHYLENEDIOXYPHENYL)-9-MORPHOLINOETHYLIMIDAZO[1,2-a]BENZIMIDAZOLE
RS58378B1 (en) 2014-07-25 2019-04-30 Taisho Pharmaceutical Co Ltd Phenyl tetrahydroisoquinoline compound substituted with heteroaryl

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754935A (en) 1969-08-13 1971-02-17 Hoechst Ag 2- (THIENYL-3'-AMINO) -1,3-DIAZACYCLOALCENES AND THEIR PREPARATION
BR6915362D0 (en) * 1969-08-16 1973-01-04 Hoechst Ag PROCESS FOR THE PREPARATION OF 2 (TIENIL-3-AMINO) 1,3-DIAZACYCLEALCHENE
DE2830279A1 (en) * 1978-07-10 1980-01-31 Boehringer Sohn Ingelheim 2-CORNER CLAMP ON N- (2'-CHLOR-4'-METHYL-THIENYL-3 ') - N- (CYCLOPROPYLMETHYL) - AMINO CORNER CLAMP ON-IMIDAZOLINE- (2), THE ACID ADDITION SALTS THAT IT INCLUDES HIS PRODUCTION
JP2002521450A (en) * 1998-07-29 2002-07-16 メルク エンド カムパニー インコーポレーテッド Integrin receptor antagonist
DE19960204A1 (en) * 1999-12-14 2001-06-28 Aventis Pharma Gmbh Substituted norlbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostic agents and medicaments containing them
CA2480638C (en) * 2002-03-29 2013-02-12 Chiron Corporation Substituted benzazoles and use thereof as raf kinase inhibitors

Also Published As

Publication number Publication date
MA27204A1 (en) 2005-01-03
CA2488242C (en) 2011-08-02
CN1659163A (en) 2005-08-24
RU2315766C2 (en) 2008-01-27
BR0311548A (en) 2005-04-12
DE50302673D1 (en) 2006-05-11
KR20050005532A (en) 2005-01-13
TNSN04240A1 (en) 2007-03-12
AR040239A1 (en) 2005-03-23
TWI283675B (en) 2007-07-11
NO329351B1 (en) 2010-10-04
MEP27608A (en) 2010-06-10
DE10224892A1 (en) 2003-12-18
DK1513834T3 (en) 2006-07-17
MY129832A (en) 2007-05-31
PT1513834E (en) 2006-06-30
HRP20041153A2 (en) 2005-06-30
WO2003101984A1 (en) 2003-12-11
RU2004138812A (en) 2005-07-20
EP1513834B1 (en) 2006-03-15
ZA200409095B (en) 2005-05-10
ES2258722T3 (en) 2006-09-01
CA2488242A1 (en) 2003-12-11
MXPA04011986A (en) 2005-03-07
RS51141B (en) 2010-10-31
ATE320425T1 (en) 2006-04-15
RS103804A (en) 2006-12-15
PL372589A1 (en) 2005-07-25
CN1324024C (en) 2007-07-04
EP1513834A1 (en) 2005-03-16
AU2003273553A1 (en) 2003-12-19
KR101087966B1 (en) 2011-12-01
UA77551C2 (en) 2006-12-15
CR7577A (en) 2005-06-16
JP4511924B2 (en) 2010-07-28
HK1076460A1 (en) 2006-01-20
AU2003273553B2 (en) 2008-12-04
IL165519A0 (en) 2006-01-15
TW200406409A (en) 2004-05-01
PE20040534A1 (en) 2004-10-25
ECSP045471A (en) 2005-01-28
IL165519A (en) 2010-05-31
JP2005533038A (en) 2005-11-04
OA12827A (en) 2006-07-11

Similar Documents

Publication Publication Date Title
NO20032735L (en) Diphenyllazetidinone derivatives, process for their preparation, drugs containing these compounds and their use
NO20032733D0 (en) Diphenyl azetidinone derivatives, process for their preparation, drugs containing these compounds and their use
NO20052496D0 (en) Selected CGRP antagonists, methods for their preparation and use thereof as drugs.
DK1648874T3 (en) Piperazine derivatives as well as their use as therapeutically active substances
DK1572707T3 (en) New Aromatic Fluorine Glycoside Derivatives, Drugs Containing These Compounds, and Uses thereof
NO20054790D0 (en) Use of B7-113 as an immunoregulatory agent
BRPI0312649A2 (en) compounds, pharmaceutical compositions containing them, and processes of use therefor.
NO20054876D0 (en) Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, their use as drug and drug containing such compounds
NO20052739D0 (en) CCR5 antagonists as drugs
NO20054220D0 (en) Substituted N-aryl heterocycles, process for their preparation and their use as a drug
DK1732917T3 (en) Selected CGRP antagonists, processes for their preparation, and their use as a drug
NO20030870D0 (en) Bicyclic heterocycles, drugs containing them, their use and the method of preparation thereof
NO20015816D0 (en) Indanyl-substituted benzene carbonamides, processes for their preparation, use thereof as a medicament, and pharmaceutical preparations containing them
NO20040356L (en) Indanacetic acid derivatives and their use as pharmaceutical agents, intermediates and methods of preparation.
DK1492789T3 (en) Tropane derivatives as CCR5 modulators
DK1838315T3 (en) SUBSTITUTED 4-PHENYLTETRAHYDROISOQUINOLINES, METHOD OF PREPARING IT, THEIR USE AS MEDICINE AND MEDICINES CONTAINING THEM
NO980273D0 (en) Five-membered heterocycles with biphenylsulfonyl substitution process for their preparation, their use as a drug or diagnostic, and drug containing the compound
BRPI0312413A2 (en) compounds, pharmaceutical compositions containing them, and method of use therefor
PT1560826E (en) PYRIDOPYRYIDINONE COMPOUNDS, ITS PREPARATION PROCESSES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
NO20045504L (en) Substituted thiophenes, methods of preparation, their use as a drug or diagnostic agent, and a drug containing these
DK1655030T3 (en) Benzothiadiazine Compounds, Methods of Preparation and Pharmaceutical Compositions Containing These
NO20022801D0 (en) Substituted norbornylamino derivatives, process for their preparation, their use as a drug or diagnostic as well as drugs containing these
DK1387838T3 (en) Cyanoanthranylamide derivatives and their use as drugs
DK1509498T3 (en) Pentafluorosulfanyl benzoylguanidines, processes for their preparation, use thereof as a medicament or diagnostic, and medicament containing them
DK1651677T3 (en) Heparin-derived oligosaccharide mixtures, their preparation and pharmaceutical compositions containing these mixtures

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees